An official government website affiliated with the Government of the Kingdom of Saudi Arabia.

Thu 25 Jun 2026

Beta version

Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

Registered with the Digital Government Authority under number:

20250831619

Suggestions

Tisagenlecleucel

Brand name	Kymriah
المخاطر	Potential risk of T-cell malignancy associated with the use of chimeric antigen receptor (CAR) T cell Immunotherapies Secondary malignancies of T-cell origin, including chimeric antigen receptor (CAR)- positive malignancies, have been reported within weeks and up to several years following treatment of hematological malignancies with a BCMA- or CD19-directed CAR T-cell therapy. Patients should be monitored life-long for secondary malignancies.
تاريخ الموافقة	Mon, 06/01/2020 - 12:00
Last updated date	Sun, 09/28/2025 - 12:00
Educational materials for healthcare practitioners	Download Download
Messages directed to healthcare practitioners	Download
المواد التعليمية الموجهة للمريض	Download Download Download Download
Safety messages for healthcare practitioners	Download Download